论文部分内容阅读
目的分析雾化吸入布地奈德混悬液治疗儿童支气管哮喘的临床疗效。方法 60例支气管哮喘患儿,随机分成实验组和对照组,每组30例。对照组给予抗感染、止咳化痰平喘、吸氧等常规治疗,实验组在常规治疗的基础上加用雾化吸入布地奈德混悬液治疗。比较两组治疗效果及咳嗽、喘息症状减轻、肺部哮鸣音消失、住院时间和安全性。结果实验组总有效率为96.67%,对照组总有效率为76.67%,两组比较差异有统计学意义(P<0.05)。实验组在咳嗽、喘息症状减轻、肺部哮鸣音消失、住院时间明显低于对照组,差异有统计学意义(P<0.05)。结论常规治疗联合雾化吸入布地奈德混悬液,治疗儿童支气管哮喘安全可靠,效果确切。
Objective To analyze the clinical effect of inhalation of budesonide suspension on bronchial asthma in children. Methods Sixty children with bronchial asthma were randomly divided into experimental group and control group, 30 cases in each group. The control group was given anti-infection, cough and phlegm asthma, oxygen and other conventional treatment, the experimental group on the basis of conventional treatment plus inhalation of budesonide suspension treatment. The curative effects of the two groups were compared, cough, wheezing relief, disappearance of lung wheeze, length of hospital stay and safety. Results The total effective rate was 96.67% in the experimental group and 76.67% in the control group, with significant difference between the two groups (P <0.05). The experimental group in the cough, wheezing relieved, lung wheeze disappeared, hospitalization was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion Conventional treatment combined inhalation of budesonide aerosol suspension, the treatment of children with bronchial asthma safe and reliable, the exact effect.